by Jason Heaviland | Nov 21, 2025
Unlocking FFPE Archives: How TissueBridge™️ Enables Retrospective Profiling of Tumor Metabolism Panome Bio’s TissueBridge technology unlocks the full metabolomic potential of FFPE tissue archives, enabling comprehensive, high-confidence profiling of tumor metabolism...
by ODWAdmin | Sep 22, 2025
Comprehensive Biological Profiling in Cancer via Multi-Omics Integration Colorectal cancer is on the rise and remains difficult to detect and treat. Panome Bio’s multi-omics platform combines metabolomics and proteomics to reveal how molecules interact across...
by ODWAdmin | Sep 10, 2025
Dive into the power of Panome Bio’s Next-Generation Metabolomics in this sample data report. See how Panome Bio used untargeted metabolomics workflow to analyze tumor and normal adjacent tissue from fresh-frozen samples.
by ODWAdmin | Sep 8, 2025
Combining Metabolomics, Proteomics and Transcriptomics to Reveal Key Pathways and Biomarkers Explore how reduced KRAS activity reshapes gene expression and pathway activity in HCT-116 cells. In this application note, Panome Bio combines next-generation metabolomics,...
by ODWAdmin | Sep 6, 2025
Metabolic Profiling of Tumor and Normal Adjacent FFPE Tissue Panome Bio is excited to announce a new, fully validated service that brings comprehensive, untargeted metabolomics to formalin-fixed paraffin-embedded (FFPE) samples, TissueBridge Metabolomics. Expanding...
